Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling

Figure 3

JUB ameliorated the depression-like behavior. Biochemical tests (a–b), sucrose preference (c), locomotion scores, and exploratory scores (d–e) before and after JUB (40 mg/kg/day) or vehicle administration for 2 weeks. (f) Movement of open-field test. Data are (). .

(a)

(b)

(c)

(d)

(e)

(f)